glp 1 agonist delayed gastric emptying GLP-1 medications safe to continue before surgery in patients with diabetes and obesity Reflections on the discovery GLP-1

Differences in clinical efficacy have been observed in headtohead comparisons between GLP1RAs in randomised controlled trials

[DOI] [PubMed] [Google Scholar] 216.Zhang Y.L., et al

A new survey report from the International Foundation of Employee Benefit Plans reveals results from a group of Canadian employers regarding considerations and coverage for glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes and are increasingly being used to treat obesity

doi: 10.1111/jsr.70196 46

We are in a new era for obesity pharmacotherapy where combinations of entero-pancreatic hormones approach the WL achieved with bariatric surgery

L., Calanna, S., Davies, M., Van Gaal, L